Browsing Tag
Artrya Limited
2 posts
ASX top 10 losers on October 5: Vanadium Resources slides 13% as resources dominate
Vanadium Resources Limited fell 13.12% to lead the ASX losers on October 5, while resources stocks took nine of the top 10 places and trading activity was heavily concentrated in Vanadium Resources and ARTRYA Limited.
October 5, 2026
Artrya (ASX: AYA) shares rise 3.3% as A$74m cash backs US Salix commercial rollout
Artrya has moved from clinical development into early United States commercialisation, with three health-system customers and its first Salix revenues now established. The company enters FY27 with A$74 million of cash and no debt, but FY26 statutory revenue remained only A$28,000 while operating investment drove the annual loss materially higher.
September 1, 2026